Qiagen Gmbh is a company established in 1984 in Duesseldorf, Germany.
In 1986 Qiagen already introduced a revolutionary change in molecular biology by the first plasmid kit which shortened a time necessary to prepare material from bacterial DNA from 2-3 days on 2 hours.
In following period Qiagen opened subunits around the world with constant investment in process of automation diagnostics and the development of innovative technologies.
During 2007 Qiagen merges with Digene Corporation, thus becoming the technological leader in molecular diagnostics.
The company includes two organizational areas of work: Life Sciences and Molecular Diagnostics.
Beohem-3 d.o.o. is a marketing authorization holder in Serbia for a world renowned hybrid capture program for detection of HPV.
More information on www.qiagen.com.